DUBAI-FUTURE-FOUNDATION
Dubai is increasingly becoming a global center for artificial intelligence. To this end, the metropolis of the day after tomorrow on the Gulf has pledged to train one million people in AI prompting over the next three years with Dubai Future Foundation overseeing the AI prompt program.. It is the first program of its kind in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613025960/en/
Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. (Photo: Business Wire)
“We want to be the most future-ready city and continue to prepare for the AI era by developing expertise and skills that support global technological change and put Dubai at the forefront of innovation,” said the Chairman of the Board of Trustees of the Dubai Future Foundation (DFF), Crown Prince Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, at the launch of the 'One Million AI Prompters' initiative in Dubai.
The United Arab Emirates, in which Dubai is the most important emirate alongside Abu Dhabi, is preparing for the post-oil era and wants to transform itself from an oil state into an AI power. By 2031, 40 percent of the gross domestic product is to be generated with artificial intelligence. To this end, the UAE is investing billions, has appointed the world's first Minister of State for AI, is attracting scientists to the Gulf, and is providing massive support for start-ups.
AI prompt engineering is critical to getting the best out of generative AI. It involves understanding the capabilities, limitations, and nuances of AI models and is predicted to be one of the most important skills in the future workplace.
‘One Million AI Prompters’, the first-of-its-kind prompt engineering initiative, that prepares expertise and competencies in AI prompt engineering, which involves crafting precise and effective instructions for AI systems to achieve desired outcomes in various tasks, ranging from generating creative content to solving complex challenges.
"We want to show people that there is a full spectrum of use cases. Whether you are technical or non-technical, you can utilize these tools,” said Omar Al Olama, the UAE´s Minister of State for AI, Digital Economy, and Remote Work Applications. He also highlighted the importance of developing practical prompt engineering skills, as these are crucial for the workforce of tomorrow and for enhancing quality of life through AI. Al Olama was appointed as the world's first AI Minister of State in the UAE in 2017.
World Championship in AI Prompt in Dubai
To launch the ‘One Million AI Prompters’ initiative, the first Global Prompt Engineering Championship was recently held in Dubai. Participants competed in categories beyond traditional coding, such as literature and art, highlighting the broad applicability of AI tools. In AI, a prompt refers to a specific request to a language model (e.g. ChatGPT or others) that can provide the user with an answer or solution.
The Global Prompt Engineering Championship received thousands of entries from around 100 countries. Thirty finalists from 13 countries qualified to come to Dubai to compete for the title of best prompt engineer in the competition's three categories. The winners were Australian Megan Fowkes in the art category Indian Ajay Cyril, 33, for coding, and Aditya Nair, 34, in literature. The Dubai Centre for Artificial Intelligence (DCAI) provided one million dirhams, approximately 273,000 US dollars, in prize money for the three winners.
Global competition around the United Arab Emirates
The UAE is increasingly being courted as a strategic partner by global tech giants. Microsoft, Google, and IBM already took part in the first championship with workshops. However, other companies and countries have also expressed interest in AI collaborations. There has been an AI university in the UAE since 2019 and the sovereign wealth fund Mubadala has set up a $100 billion AI fund.
Microsoft recently invested $1.5 billion in G42, the leading UAE-based artificial intelligence (AI) technology holding company. The US software giant recognizes the Gulf state's leading role in the development of artificial intelligence: “This strategic investment will enhance the UAE’s position as a global AI hub and provide further opportunities for partners and customers to innovate and grow”.
For more information on the Global Prompt Engineering Championship, please visit:
https://challenge.dub.ai/en/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240613025960/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Illumynt Reports Q3 2025 Business Update17.10.2025 14:39:00 CEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia17.10.2025 14:15:00 CEST | Press release
Avanzanite entered an exclusive partnership with Agios in June 2025 to manage PYRUKYND commercialization across Europe European Commission will now review the CHMP’s opinion, with the final decision expected by early 2026 PYRUKYND is currently approved in Europe for adults with PK deficiency; thalassemia would represent its second indication, pending European Commission approval Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the new indication for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for t
Kinaxis Accelerates Agentic Era for Supply Chain Orchestration with the Launch of Maestro Agents17.10.2025 13:00:00 CEST | Press release
AI agents that plan with you, not just for you, empower the customer journey to a next generation of the adaptive supply chain Kinaxis® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced Maestro Agents, marking the next milestone in AI-enabled decision intelligence for supply chains. Now available to Kinaxis customers and embedded natively in Kinaxis Maestro®, these AI-powered context aware digital co-workers help planners move faster from issue to action, turning disruption into opportunity, and strengthening the resilience of the supply chains that power the global economy. “Kinaxis agents are already helping our planning team collaborate more effectively with customers and contract manufacturers,” said John Finnigan, Senior Director, Advanced Planning at Jabil. “With human-in-the-loop safeguards, we’re reaching decisions faster today and see strong potential to build a more resilient and networked supply chain.” Maestro Agents advance the customer journe
SLB Announces Third-Quarter 2025 Results17.10.2025 12:50:00 CEST | Press release
Revenue of $8.93 billion increased 4% sequentially and decreased 3% year on year GAAP EPS of $0.50 decreased 32% sequentially and 40% year on year EPS, excluding charges and credits, of $0.69 decreased 7% sequentially and 22% year on year Net income attributable to SLB of $739 million decreased 27% sequentially and 38% year on year Adjusted EBITDA of $2.06 billion was flat sequentially and decreased 12% year on year Cash flow from operations was $1.68 billion and free cash flow was $1.10 billion, including $153 million of acquisition-related payments Board approved quarterly cash dividend of $0.285 per share SLB (NYSE: SLB) today announced results for the third-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015948706/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2025Jun. 30, 2025Sept. 30, 2024Se
Dompé's Program in NAION Selected for Landmark FDA Commissioner’s National Priority Voucher Program17.10.2025 02:42:00 CEST | Press release
One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who urgently need them.With this selection, Dompé receives a voucher shortening the marketing application review from the standard 10–12 months to just 1–2 months.Dompé plans to apply the voucher to its Biologics License Application (BLA) for an intranasal form of Nerve Growth Factor (Cenegermin-bkbj) for the treatment of non-arteritic anterior ischemic optic neuropathy (NAION).Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and the US, announced today its selection by the United States Food and Drug Administration (FDA) to participate in the Commissioner’s National Priority Voucher (CNPV) program. Because of its select
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom